Verana Health has launched new functionality within its Site Explorer and Verana Trial Connect applications to streamline clinical trial site selection and patient enrollment. The updates include real-time dashboards that allow sponsors and contract research organisations to monitor deidentified screening activity across sites and accelerate decision-making. The platform leverages real-world data from exclusive partnerships with the American Academy of Ophthalmology IRIS Registry and American Urological Association Quality Registry, providing access to electronic health record data on over 95 million deidentified patients from more than 3,200 practices. Site Explorer helps sponsors identify suitable patient populations, whilst Verana Trial Connect automates eligibility review and streamlines pre-screening workflows. The company aims to address common trial challenges including underperforming sites and limited visibility into patient volumes.

Verana Health has introduced the world's largest curated real-world dataset for prostate cancer, comprising data from over 430,000 patients. The dataset captures critical variables including Gleason Score, TNM Stage, PSA levels and castration status to support clinical research into disease detection, treatment and outcomes. As the exclusive data and analytics partner of the American Urological Association Quality Registry, Verana Health uses AI and large language models to transform unstructured electronic health record data into research-ready datasets. The company's network was recently expanded through a merger with COTA, providing access to over 30 academic medical centres and 10 million oncology patients. The dataset aims to support early detection, treatment validation and clinical trial recruitment for prostate cancer, which affects roughly one in nine men in the US.

Verana Health has released Agent Claire, an AI agent designed to assist clinicians with Merit-based Incentive Payment System (MIPS) submissions tied to Medicare reimbursement. The tool is now available in the Quality Measures Dashboard for qualifying members of the American Academy of Ophthalmology IRIS Registry. Agent Claire helps medical practices navigate MIPS compliance by unifying data for actionable insights, staying current with reporting requirement changes, and accurately submitting data whilst minimising administrative burden. The AI agent aims to help clinicians maximise programme performance while maintaining focus on patient care. According to Deloitte, 78% of biopharma and medtech leaders expect AI to drive major organisational change in 2026. Verana Health plans to extend Agent Claire's capabilities across its software-as-a-service applications for life sciences organisations.